201 related articles for article (PubMed ID: 27720342)
1. National and State-Specific Shingles Vaccination Among Adults Aged ≥60 Years.
Lu PJ; O'Halloran A; Williams WW; Harpaz R
Am J Prev Med; 2017 Mar; 52(3):362-372. PubMed ID: 27720342
[TBL] [Abstract][Full Text] [Related]
2. Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
Draper M; Stergiopoulos S
Vaccine; 2021 Nov; 39(46):6781-6786. PubMed ID: 34625290
[TBL] [Abstract][Full Text] [Related]
3. Shingles Vaccination of U.S. Adults Aged 50-59 Years and ≥60 Years Before Recommendations for Use of Recombinant Zoster Vaccine.
Lu PJ; Hung MC; Srivastav A; Williams WW; Dooling KL
Am J Prev Med; 2020 Jul; 59(1):21-31. PubMed ID: 32389533
[TBL] [Abstract][Full Text] [Related]
4. Noninfluenza vaccination coverage among adults - United States, 2012.
Williams WW; Lu PJ; O'Halloran A; Bridges CB; Pilishvili T; Hales CM; Markowitz LE;
MMWR Morb Mortal Wkly Rep; 2014 Feb; 63(5):95-102. PubMed ID: 24500288
[TBL] [Abstract][Full Text] [Related]
5. Assessing and Improving Zoster Vaccine Uptake in a Homeless Population.
Kaplan-Weisman L; Waltermaurer E; Crump C
J Community Health; 2018 Dec; 43(6):1019-1027. PubMed ID: 29730833
[TBL] [Abstract][Full Text] [Related]
6. Shingles Vaccination Among Adults Aged 60 and Over: United States, 2018.
Terlizzi EP; Black LI
NCHS Data Brief; 2020 Jul; (370):1-8. PubMed ID: 32730737
[TBL] [Abstract][Full Text] [Related]
7. Determinants of shingles vaccine acceptance in the United Kingdom.
Bricout H; Torcel-Pagnon L; Lecomte C; Almas MF; Matthews I; Lu X; Wheelock A; Sevdalis N
PLoS One; 2019; 14(8):e0220230. PubMed ID: 31369608
[TBL] [Abstract][Full Text] [Related]
8. Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.
Williams WW; Lu PJ; O'Halloran A; Bridges CB; Kim DK; Pilishvili T; Hales CM; Markowitz LE;
MMWR Morb Mortal Wkly Rep; 2015 Feb; 64(4):95-102. PubMed ID: 25654611
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic predictors of variation in coverage of the national shingles vaccination programme in England, 2014/15.
Ward C; Byrne L; White JM; Amirthalingam G; Tiley K; Edelstein M
Vaccine; 2017 Apr; 35(18):2372-2378. PubMed ID: 28363324
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.
Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Fiebelkorn AP
MMWR Surveill Summ; 2017 May; 66(11):1-28. PubMed ID: 28472027
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
13. Community and patient values for preventing herpes zoster.
Lieu TA; Ortega-Sanchez I; Ray GT; Rusinak D; Yih WK; Choo PW; Shui I; Kleinman K; Harpaz R; Prosser LA
Pharmacoeconomics; 2008; 26(3):235-49. PubMed ID: 18282017
[TBL] [Abstract][Full Text] [Related]
14. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
16. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for Health Care Access and Health Services Use, Adults Aged 18-64 Years - Behavioral Risk Factor Surveillance System, United States, 2014.
Okoro CA; Zhao G; Fox JB; Eke PI; Greenlund KJ; Town M
MMWR Surveill Summ; 2017 Feb; 66(7):1-42. PubMed ID: 28231239
[TBL] [Abstract][Full Text] [Related]
18. National and State-Specific Td and Tdap Vaccination of Adult Populations.
Lu PJ; O'Halloran A; Ding H; Liang JL; Williams WW
Am J Prev Med; 2016 May; 50(5):616-626. PubMed ID: 26614276
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with shingles and pneumococcal vaccination among older Canadians.
Gilmour H
Health Rep; 2024 Jan; 35(1):14-24. PubMed ID: 38232409
[TBL] [Abstract][Full Text] [Related]
20. Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
Matthews I; Lu X; Dawson H; Bricout H; O'Hanlon H; Yu E; Nozad B
Vaccine; 2018 Nov; 36(46):7105-7111. PubMed ID: 30195489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
